Business
Mobile-health Network Solutions Offers GLP-1 Injectables for Medical Weight Loss from $10/day
SINGAPORE - (NewMediaWire) - June 18, 2024 - Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth
About this update from Mobile-health Network Solutions
[{"type":"text","content":"SINGAPORE - (NewMediaWire) - June 18, 2024 - Mobile-health Network Solutions (Nasdaq: MNDR) (\"MaNaDr\" or \"the Company\"), a leading Asia-Pacific telehealth provider, today announced updated pricing to its medical weight management program to improve affordability and accessibility to glucagon-like peptide 1 (\"GLP-1\") receptor agonists medications in the Asia-Pacific (\"APAC\") region. \nThe program, designed to stem the growing prevalence of obesity in Singapore and surrounding nations, is believed to be amongst the most competitively priced in the region, said the Company. As a result, MaNaDr expects the program will have a significant adoption rate and provide meaningful incremental revenue to the Company starting in the third quarter of the current calendar year.\n\"Leveraging our strong partnerships, we offer a range of GLP-1 medications directly sourced from the leading pharmaceutical innovators,\" said Ms. Law Pei Bei, Chief Business Officer. \"This means patients have access to the original, brand-name GLP-1 injections, ensuring the highest quality and proven results.\n\"We've negotiated competitive pricing with these leading pharmaceutical manufacturers, allowing us to offer these original GLP-1 medications at pricing starting at less than US$10 per day. This low pricing makes these treatments a realistic option for most weight management patients.\"\nCo-CEO Dr. Siaw Tung Yeng, PBM, Senior Consultant Family Physician, added, \"Telehealth consultations create a safe and comfortable environment for weight management discussions. This is especially beneficial for individuals who may experience shyness, social anxiety, or fear in a traditional setting. Telehealth empowers these patients to openly discuss their weight loss goals and challenges, fostering a supportive foundation for their journey.\"\nMarketed with the tagline, \"It's Okay to Not Be Okay,\" the MaNaDr program is among the few of its kind in the APAC region to offer a one-stop source for patients' weight management needs. Services provided include:\nMedical Intervention. Patients can consult with doctors for personalized medical advice, including the suitability of using GLP-1 medications such as Semaglutide (brand names Wegovy and Rybelsus), Liraglutide (Saxenda), Dulaglutide (Trucility), or other prescription weight loss medications. \nMental/Emotional Su...